hotspot -WSS

hotspot

author：leisure time 2025-08-11 09:49:05 - browse：63

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT Summit: How a Chicago ER doctor tackles gun violence

WSS

FDA struggles to regulate food additives, sometimes for decades

Ending health disparities requires full federal government, panel says

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

Impact of Dobbs ruling felt at reproductive medicine meeting

VC firm RA Capital starts a new synthetic biology incubator

knowledge

hotspot

hotspot

Drug repurposing or repositioning? The language matters

HHS leader on health, climate change and biopharma emissions

Medicare proposal to cover medical devices draws a mixed reaction

STAT Summit: How a Chicago ER doctor tackles gun violence

Dobbs anniversary: the lost opportunity of abortion as health care

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Medicare proposal to cover medical devices draws a mixed reaction

The mammogram wars are not over

Malaria cases in Florida and Texas: Here’s what you need to know

The explosion of genetic testing requires a new approach

focus

An outrageous hospital charge: I paid $710 for an hour of babysitting

Why health workers in Gaza are injured or die at high rates

FDA gives detailed accounting of AI

FDA warns J&J's Abiomed: We will regulate your software

American Airlines has a tentative contract deal with its pilots. Southwest is still negotiating

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

focus

Wikipedia

explore

explore